Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109857 · ClinicalTrials.gov registry record
Bladder Bank (a Prospective Banking Study)
A clinical trial of Bladder Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT06109857: Recruiting study of Bladder Carcinoma, sponsored by Mayo Clinic.
NCT06109857 is a study of Bladder Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,500 participants, below the 3,399-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06109857, a study of Bladder Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Primary Outcome
At study enrollment for subjects, 60 ml (4 tablespoons) of blood will be drawn from all participants and processed according to standardized study biospecimen protocol. All samples will be stored for future analysis in Molecular Cancer Diagnostic Laboratory at Mayo Clinic.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2027-12-01 |
What NCT06109857 shows while recruiting
NCT06109857 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 3,399-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Bladder Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06109857 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06109857 about?
NCT06109857 is a clinical study titled "Bladder Bank (a Prospective Banking Study)". This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
What is the current status of trial NCT06109857?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2022-07-06. Estimated completion is 2027-12-01.
What conditions does trial NCT06109857 study?
This clinical trial studies the following conditions: Bladder Carcinoma.
What interventions are being tested in trial NCT06109857?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06109857?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06109857 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06109857's enrollment target sits among peer trials
1,500 4th of 10 higher than 7 of 10 other Bladder Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bladder Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
RECRUITING
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RECRUITING
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI